Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.54 - $1.41 $493,295 - $1.29 Million
-913,510 Closed
0 $0
Q1 2022

Feb 14, 2023

BUY
$1.4 - $5.15 $1.28 Million - $4.7 Million
913,510 New
913,510 $1.32 Million
Q1 2022

May 13, 2022

SELL
$1.4 - $5.15 $605,512 - $2.23 Million
-432,509 Reduced 32.13%
913,510 $1.32 Million
Q4 2021

Feb 14, 2022

SELL
$4.27 - $6.97 $1.03 Million - $1.69 Million
-242,329 Reduced 15.26%
1,346,019 $7.03 Million
Q3 2021

Nov 15, 2021

SELL
$5.31 - $8.25 $250,440 - $389,103
-47,164 Reduced 2.88%
1,588,348 $9.26 Million
Q2 2021

Aug 13, 2021

BUY
$6.81 - $9.23 $62,257 - $84,380
9,142 Added 0.56%
1,635,512 $13.2 Million
Q1 2021

May 14, 2021

SELL
$7.99 - $15.0 $261,209 - $490,380
-32,692 Reduced 1.97%
1,626,370 $13.5 Million
Q4 2020

Feb 12, 2021

SELL
$7.04 - $11.7 $997,807 - $1.66 Million
-141,734 Reduced 7.87%
1,659,062 $12.6 Million
Q3 2020

Nov 13, 2020

SELL
$9.98 - $18.04 $2.39 Million - $4.32 Million
-239,610 Reduced 11.74%
1,800,796 $19.2 Million
Q2 2020

Aug 14, 2020

BUY
$7.49 - $15.16 $316,437 - $640,479
42,248 Added 2.11%
2,040,406 $30.9 Million
Q1 2020

May 15, 2020

SELL
$4.62 - $18.74 $206,421 - $837,303
-44,680 Reduced 2.19%
1,998,158 $16.6 Million
Q4 2019

Feb 18, 2020

BUY
$14.6 - $18.13 $3.66 Million - $4.54 Million
250,407 Added 13.97%
2,042,838 $34.5 Million
Q3 2019

Nov 14, 2019

BUY
$16.62 - $23.92 $497,370 - $715,829
29,926 Added 1.7%
1,792,431 $33.3 Million
Q2 2019

Aug 13, 2019

BUY
$17.79 - $22.88 $23.6 Million - $30.3 Million
1,326,233 Added 303.99%
1,762,505 $40.3 Million
Q1 2019

May 14, 2019

SELL
$11.76 - $22.15 $453,936 - $854,990
-38,600 Reduced 8.13%
436,272 $9.17 Million
Q4 2018

Feb 13, 2019

BUY
$10.42 - $21.94 $741,591 - $1.56 Million
71,170 Added 17.63%
474,872 $5.46 Million
Q3 2018

Nov 08, 2018

BUY
$20.4 - $24.6 $473,769 - $571,310
23,224 Added 6.1%
403,702 $9.27 Million
Q2 2018

Aug 13, 2018

BUY
$19.02 - $24.95 $1.29 Million - $1.7 Million
67,958 Added 21.75%
380,478 $8.49 Million
Q1 2018

May 14, 2018

BUY
$22.55 - $29.9 $33,825 - $44,850
1,500 Added 0.48%
312,520 $7.14 Million
Q4 2017

Feb 13, 2018

SELL
$18.0 - $30.0 $2.19 Million - $3.65 Million
-121,627 Reduced 28.11%
311,020 $8.15 Million
Q3 2017

Nov 13, 2017

BUY
$21.1 - $25.15 $9.13 Million - $10.9 Million
432,647
432,647 $9.71 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.